Competition can be tough for funding from science funding organizations like the National Institutes of Health (NIH), and these organizations are not able to support all projects that are potentially deserving. If your high-scoring grant application is not selected for funding, there’s a new option: Submit your work to the Online Partnership to Accelerate Research (OnPAR), an opportunity providing second chances to grant applications which are turned down by funding agencies such as NIH, the European Commission, or the UK Department of Health.
This second chance opportunity is available to researchers who submit a grant application to a funding agency and receives high scores in the review process but is not selected for funding (e.g., falls within the 30th percentile during NIH review). Through this partnership, organized by Leidos Health’s Life Sciences Division, private biomedical foundations and industries such as the Epilepsy Foundation, Children’s Tumor Foundation, or JDRF then have the opportunity to review and fund your work.
“The list of research of interest to OnPAR foundations and industries is diseased focused, but many of these diseases have considerable social and behavioral aspects, including diabetes, arthritis, lupus, Crohn’s disease, Alzheimer’s, heart disease, stroke, and peripheral arterial disease. OnPAR is also interested in research on wearable technologies and smartphone applications for early detection of disease initiation and progression,” reads a recent announcement about OnPAR on NIH’s Office of Behavioral and Social Sciences Research blog.
To apply for potential funding via OnPAR, researchers should register and submit unfunded but well-scoring applications via the OnPAR website.
Click here to learn more about the second chance for grant funding offered by OnPAR.